Production (Stage)
Lotus Bio-Technology Development Corp.
LBTD
$0.00
$0.000.00%
OTC PK
| 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.60K | 33.00K | 20.80K | 22.20K | 789.30K |
| Depreciation & Amortization | -1.60K | -1.60K | -1.60K | -1.60K | 1.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.00K | 31.40K | 19.20K | 20.60K | 790.40K |
| Operating Income | -14.00K | -31.40K | -19.20K | -20.60K | -790.40K |
| Income Before Tax | -12.90K | -30.30K | -18.10K | -19.50K | -791.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.01 | -0.03 | -0.02 | -0.02 | -0.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.90K | -30.30K | -18.10K | -19.50K | -791.00K |
| EBIT | -14.00K | -31.40K | -19.20K | -20.60K | -790.40K |
| EBITDA | -- | -11.80K | -11.80K | -12.30K | -779.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 631.64M | 380.01M | 331.10M | 331.10M | 430.61M |
| Average Diluted Shares Outstanding | 631.64M | 380.01M | 331.10M | 331.10M | 430.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |